Chimeric Therapeutics Limited (ASX:CHM)

Chimeric Therapeutics Revenue

Chimeric Therapeutics had revenue of 7.13M AUD in the half year ending June 30, 2025, with 376.67% growth. This brings the company's revenue in the last twelve months to 9.75M, up 377.63% year-over-year. In the fiscal year ending June 30, 2025, Chimeric Therapeutics had annual revenue of 12.68M with 70.09% growth.

• Revenue (ttm): 9.75M
• Revenue Growth: +377.63%
• P/S Ratio: 0.91
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.84M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.68M	5.23M	70.09%
Jun 30, 2024	7.46M	2.95M	65.52%
Jun 30, 2023	4.51M	1.89M	72.16%
Jun 30, 2022	2.62M	-	-
Jun 30, 2021	-	-	-